Records 1 - 18
| Association between Molecular Genetic Markers of DNA Repair and Cell Cycle Control Genes and Response to Platinum-Based Chemotherapy in Ovarian Cancer Patients.
Bulletin of experimental biology and medicine 2021 Oct .
Zavarikina T M, Khokhlova S V, Tyulyandina A S, Khabas G N, Asaturova A V, Nosova Yu V, Brenner P K, Kapralova M A, Khodirev D S, Stenina M
| The Association of Polymorphisms in Base Excision Repair Genes with Ovarian Cancer Susceptibility in Chinese Women: A Two-Center Case-Control Study.
Journal of Cancer 2021 12 (1): 264-269.
Zhang Mingyao, Zhao Zhiguang, Chen Sailing, Liang Zongwen, Zhu Jiawei, Zhao Manman, Xu Chaoyi, He Jing, Duan Ping, Zhang An
| ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy.
Asian Pacific journal of cancer prevention : APJCP 2020 Jul 21 (7): 1925-1929.
Liblab Salisa, Vusuratana Apichai, Areepium Nuttha
| Single nucleotide polymorphisms (SNPs) of hOGG1 and XRCC1 DNA repair genes and the risk of ovarian cancer in Polish women.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015 Jun .
Michalska Magdalena M, Samulak Dariusz, Romanowicz Hanna, Bie?kiewicz Jan, Sobkowski Maciej, Ciesielski Krzysztof, Smolarz Bea
| CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer.
Frontiers in oncology 2015 5 123.
Lee Jung-Min, Trepel Jane B, Choyke Peter, Cao Liang, Sissung Tristan, Houston Nicole, Yu Minshu, Figg William D, Turkbey Ismail Baris, Steinberg Seth M, Lee Min-Jung, Ivy S Percy, Liu Joyce F, Matulonis Ursula A, Kohn Elise
| Association among XRCC1, XRCC3, and BLHX gene polymorphisms and chromosome instability in lymphocytes from patients with endometriosis and ovarian cancer.
Genetics and molecular research : GMR 2014 13 (1): 636-48.
Monteiro M S, Vilas Boas D B, Gigliotti C B, Salvadori D M
| Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population.
Molecular and cellular biochemistry 2013 Jan 372 (1-2): 27-33.
Li Kai, Li Wushe
| DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
Asian Pacific journal of cancer prevention : APJCP 2013 14 (2): 941-6.
Kang Shan, Sun Hai-Yan, Zhou Rong-Miao, Wang Na, Hu Pei, Li Y
| Prediction value of XRCC 1 gene polymorphism on the survival of ovarian cancer treated by adjuvant chemotherapy.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (10): 10.
Miao J, Zhang X, Tang QL, Wang XY, Kai L
| Predictive value of XRCC1 and XRCC3 gene polymorphisms for risk of ovarian cancer death after chemotherapy.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (6): 6.
Cheng CX, Xue M, Li K, Li WS
| [Association of polymorphisms in glutathione-S-transferase and DNA repair genes with ovarian cancer risk in the Russian population].
Genetika 2012 Jul 48 (7): 901-4.
Khokhrin D V, Khrunin A V, Moiseev A A, Gorbunov V A, Limborskaia S
| Predictive value of excision repair cross-complementing rodent repair deficiency complementation group 1 and ovarian cancer risk.
Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 1799-802.
He Shan-Yang, Xu Lin, Niu Gang, Ke Pei-Qi, Feng Miao-Miao, Shen Hong-W
| Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.
International journal of molecular epidemiology and genetics 2011 2 (2): 185-95.
Peethambaram Prema, Fridley Brooke L, Vierkant Robert A, Larson Melissa C, Kalli Kimberly R, Elliott Elaine A, Oberg Ann L, White Kristin L, Rider David N, Keeney Gary L, Cunningham Julie M, Hartmann Lynn C, Goode Ellen
| Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients.
The pharmacogenomics journal 2010 Feb 10 (1): 54-61.
Khrunin A V, Moisseev A, Gorbunova V, Limborska
| Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study.
Gynecologic oncology 2009 May 113 (2): 264-9.
Kim Hee Seung, Kim Mi-Kyung, Chung Hyun Hoon, Kim Jae Weon, Park Noh Hyun, Song Yong Sang, Kang Soon Be
| Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Oct 25 (29): 4528-35.
Marsh Sharon, Paul Jim, King Cristi R, Gifford Gillian, McLeod Howard L, Brown Robe
| Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma.
Cancer research 2007 Feb 67 (3): 1395-404.
Berndt Sonja I, Huang Wen-Yi, Fallin M Daniele, Helzlsouer Kathy J, Platz Elizabeth A, Weissfeld Joel L, Church Timothy R, Welch Robert, Chanock Stephen J, Hayes Richard
| DNA base excision repair genes variants rs25487 (X-ray repair cross-complementing 1) and rs1052133 (human 8-oxoguanine glycosylase 1) with susceptibility to ovarian cancer in the population of the Jammu region, India.
Journal of cancer research and therapeutics 0 15 (6): 1270-1275.
Verma Sonali, Sharma Varun, Nagpal Ashna, Bhat Amrita, Bhat G R, Shah Ruchi, Wakhloo Ajay, Suri Jyotsna, Abrol Deepak, Kaul Sandeep, Bhat Audesh, Verma Vijeshwar, Kumar Rake